Literature DB >> 3032781

Antibody-independent killing of gram-negative bacteria via the classical pathway of complement.

M Loos, F Clas.   

Abstract

The experiments in this paper provided evidence that, besides lipopolysaccharides (LPS), porins of gram-negative bacteria bind to C1q and C1. From these experiments, we concluded that the association of LPS and porins (outer membrane proteins, OMP) may potentiate the C1q and C1 binding in the absence of specific antibodies. This antibody independent binding of C1 to LPS and porins is a prerequisite for the activation of the classical pathway of complement leading to the killing of serum-sensitive bacteria.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032781     DOI: 10.1016/0165-2478(87)90102-7

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  14 in total

1.  Protective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice.

Authors:  Prathiba Kurupati; N P Ramachandran; Chit Laa Poh
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

2.  Antibody-independent binding of complement component C1q by Legionella pneumophila.

Authors:  C S Mintz; P I Arnold; W Johnson; D R Schultz
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

3.  Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway.

Authors:  Lee Aun Tan; Andrew C Yang; Uday Kishore; Robert B Sim
Journal:  Protein Cell       Date:  2011-05-15       Impact factor: 14.870

4.  In vitro evaluation of the role of humoral immunity against Bartonella henselae.

Authors:  M C Rodriguez-Barradas; J C Bandres; R J Hamill; J Trial; J E Clarridge; R E Baughn; R D Rossen
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

5.  C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins.

Authors:  S Albertí; G Marqués; S Camprubí; S Merino; J M Tomás; F Vivanco; V J Benedí
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

Review 6.  Complement resistance in microbes.

Authors:  M C Moffitt; M M Frank
Journal:  Springer Semin Immunopathol       Date:  1994

7.  Role of surface-exposed loops of Haemophilus influenzae protein P2 in the mitogen-activated protein kinase cascade.

Authors:  Stefania Galdiero; Domenica Capasso; Mariateresa Vitiello; Marina D'Isanto; Carlo Pedone; Massimiliano Galdiero
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

8.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

9.  Solid-phase C1q-directed bacterial capture followed by PCR for detection of Chlamydia trachomatis in clinical specimens.

Authors:  P Herbrink; H A van den Munckhof; H G Niesters; W H Goessens; E Stolz; W G Quint
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

10.  The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes.

Authors:  M A Seelen; P Athanassiou; W A Lynn; P Norsworthy; M J Walport; J Cohen; K A Davies
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.